Vericel Corp. (VCEL)
42.53
-0.44
(-1.02%)
USD |
NASDAQ |
Oct 23, 16:00
42.55
+0.02
(+0.05%)
After-Hours: 20:00
Vericel Market Cap : 2.176B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.176B |
| October 22, 2026 | 2.199B |
| October 21, 2026 | 2.095B |
| October 20, 2026 | 2.077B |
| October 19, 2026 | 2.066B |
| October 16, 2026 | 2.053B |
| October 15, 2026 | 2.099B |
| October 14, 2026 | 2.060B |
| October 13, 2026 | 2.062B |
| October 12, 2026 | 2.079B |
| October 09, 2026 | 2.052B |
| October 08, 2026 | 2.049B |
| October 07, 2026 | 2.085B |
| October 06, 2026 | 2.049B |
| October 05, 2026 | 2.102B |
| October 02, 2026 | 2.055B |
| October 01, 2026 | 2.018B |
| September 30, 2026 | 2.054B |
| September 29, 2026 | 2.078B |
| September 28, 2026 | 2.059B |
| September 25, 2026 | 2.032B |
| September 24, 2026 | 2.011B |
| September 23, 2026 | 1.985B |
| September 22, 2026 | 2.058B |
| September 21, 2026 | 2.024B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.048B |
| September 17, 2026 | 2.048B |
| September 16, 2026 | 2.058B |
| September 15, 2026 | 2.033B |
| September 14, 2026 | 2.026B |
| September 11, 2026 | 1.962B |
| September 10, 2026 | 1.938B |
| September 09, 2026 | 1.995B |
| September 08, 2026 | 2.000B |
| September 04, 2026 | 2.057B |
| September 03, 2026 | 2.071B |
| September 02, 2026 | 2.092B |
| September 01, 2026 | 2.072B |
| August 31, 2026 | 2.042B |
| August 28, 2026 | 2.095B |
| August 27, 2026 | 2.107B |
| August 26, 2026 | 2.172B |
| August 25, 2026 | 2.212B |
| August 24, 2026 | 2.165B |
| August 21, 2026 | 2.184B |
| August 20, 2026 | 2.155B |
| August 19, 2026 | 2.230B |
| August 18, 2026 | 2.265B |
| August 17, 2026 | 2.231B |
| August 14, 2026 | 2.262B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 504.75B |
| ADMA Biologics, Inc. | 2.407B |
| Kyntra Bio, Inc. | 18.55M |
| Conexeu Sciences, Inc. | 84.93M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
Market Cap Related Metrics
| PE Ratio | 92.00 |
| PS Ratio | 7.188 |
| PEG Ratio | 0.3394 |
| Price to Book Value | 5.881 |
| Price to Free Cash Flow | 35.70 |
| Price | 42.53 |
| Earnings Yield | 1.09% |
| PEGY Ratio | 0.3394 |
| Operating PE Ratio | 120.74 |
| Normalized PE Ratio | 92.02 |